Bronchomediastinal fistula presenting as purulent pericarditis in a healthy 32-year-old man

Aiman Smer1, Alok Saurav1, Ahmed Abuzaid1

  • 1Creighton University Medical Center, Cardiology Department, Omaha, NE, USA.

Journal of Cardiology Cases
|December 15, 2018
PubMed

Insights

Acute purulent pericarditis, a rare anaerobic bacterial infection, can be fatal if not treated promptly. This case highlights a bronchomediastinal fistula as a complication of lung infection, leading to pericarditis.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Thoracic Surgery

Background:

  • Acute purulent pericarditis is a rare but often fatal condition.
  • Anaerobic bacteria are infrequent causes of purulent pericarditis.
  • Common primary sources include esophagomediastinal fistulas and odontogenic or pleuropulmonary infections.

Observation:

  • A case of bronchomediastinal fistula, a sequela of necrotizing parenchymal infection, is presented.
  • This fistula led to secondary mediastinitis and pleuropericardial involvement.
  • The patient was immunocompetent.

Findings:

  • The study identifies *Eikenella corrodens* as a significant pathogen in intrathoracic suppurative infections.
  • Bronchomediastinal fistula can result in secondary purulent pericarditis.
  • Prompt diagnosis and treatment are crucial for survival.

Implications:

  • Physicians should consider purulent pericarditis in patients with thoracic infections, particularly those with fistulas.
  • *Eikenella corrodens* should be recognized as a potential cause of severe intrathoracic infections.
  • Early recognition and management of purulent pericarditis are critical to prevent fatal outcomes.

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
396
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
357
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
364
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
325
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
156
ATP Yield01:31

ATP Yield

Cellular respiration produces 30 - 32 ATP per glucose molecule. Although most of the ATP results from oxidative phosphorylation and the electron transport chain (ETC), 4 ATP are gained beforehand (2 from glycolysis and 2 from the citric acid cycle).
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
78.9K